Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,652,895
+$10,652,895 QoQ
Shares Held
442,396
Ownership
0.008%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#409
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 56%
Shared 0%
None 44%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$12,648,720
PutShares
450,453
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LOGAN CAPITAL MANAGEMENT INC holds $143,017,458 across 13 Drug Manufacturers - General names. PFE ranks #7 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,791 | $33,333,361 | |
| 2 | MRK |
Merck & Co., Inc.
|
155,292 | $19,955,022 | |
| 3 | ABBV |
AbbVie Inc.
|
77,182 | $19,422,078 | |
| 4 | JNJ |
Johnson & Johnson
|
62,551 | $15,886,077 | |
| 5 | NVS |
Novartis AG
|
73,584 | $11,532,084 | |
| 6 | SNY |
Sanofi
|
258,642 | $11,033,667 | |
| 7 | PFE |
Pfizer Inc
This page
|
442,396 | $10,652,895 | |
| 8 | GSK |
GSK plc
|
141,076 | $7,395,203 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,652,895 | 442,396 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,648,720 | 450,453 | Put | Other | 2026-05-08 | |
| 2025-12-31 | $10,098,319 | 405,555 | Shares | Other | 2026-02-12 | |
| 2025-09-30 | $11,658,399 | 457,551 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,598,891 | 437,248 | Shares | Other | 2025-08-01 | |
| 2025-03-31 | $15,258,785 | 602,162 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $13,954,461 | 525,988 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,800,972 | 580,545 | Shares | Other | 2024-12-06 | |
| 2024-06-30 | $15,819,472 | 565,385 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,925,363 | 573,887 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $12,955,758 | 450,009 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,202,118 | 488,457 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16,300,225 | 444,390 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $17,572,110 | 430,689 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $20,872,869 | 407,355 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $17,851,453 | 407,940 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $21,220,203 | 404,734 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $21,455,143 | 414,432 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $27,248,858 | 461,454 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $20,399,814 | 474,304 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $16,928,828 | 432,299 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $15,827,436 | 436,860 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $16,133,270 | 438,285 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $17,709,970 | 482,561 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $16,236,874 | 496,540 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $15,866,869 | 486,118 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||